Erwin Brosens

Dr. Erwin Brosens

Clinical Genetics department, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2012 in Genome Research
Verified
Journal Article
Open access
PDF file
PSPrzemyslaw Szafranski
Przemyslaw Szafranski
ADAvinash V. Dharmadhikari
Avinash V. Dharmadhikari
Erwin BrosensErwin Brosens
Erwin Brosens
PGPriyatansh Gurha
Priyatansh Gurha
KKKatarzyna E. Kołodziejska
Katarzyna E. Kołodziejska
PSPawel Stankiewicz
Pawel Stankiewicz
An unanticipated and tremendous amount of the noncoding sequence of the human genome is transcribed. Long noncoding RNAs (lncRNAs) constitute a significant fraction of non-protein-coding transcripts; however, their functions remain enigmatic. We demonstrate that deletions of a small noncoding differentially methylated region at 16q24.1, including lncRNA genes, cause a lethal lung developmental disorder, alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV), with parent-of-origin effects. We identify overlapping deletions 250 kb upstream of FOXF1 in nine patients with ACD/MPV that arose de novo specifically on the maternally inherited chromosome and delete lung-specific lncRNA genes. These deletions define a distant cis-regulatory region that harbors, besides lncRNA genes, also a differentially methylated CpG island, binds GLI2 depending on the methylation status of this CpG island, and physically interacts with and up-regulates the FOXF1 promoter. We suggest that lung-transcribed 16q24.1 lncRNAs may contribute to long-range regulation of FOXF1 by GLI2 and other transcription factors. Perturbation of lncRNA-mediated chromatin interactions may, in general, be responsible for position effect phenomena and potentially cause many disorders of human development.

12 April 2016 in Human Genetics
Verified
Journal Article
Closed access
PDF file
PSPrzemyslaw Szafranski
Przemyslaw Szafranski
TGTomasz Gambin
Tomasz Gambin
ADAvinash V. Dharmadhikari
Avinash V. Dharmadhikari
KAKadir Caner Akdemir
Kadir Caner Akdemir
SJShalini N. Jhangiani
Shalini N. Jhangiani
PSPawel Stankiewicz
Pawel Stankiewicz

16 May 2022 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
ESErika Souche
Erika Souche
SBSergi Beltran
Sergi Beltran
Erwin BrosensErwin Brosens
Erwin Brosens
JBJohn W. Belmont
John W. Belmont
MFMagdalena Fossum
Magdalena Fossum
MWMarjan M. Weiss
Marjan M. Weiss
In 2016, guidelines for diagnostic Next Generation Sequencing (NGS) have been published by EuroGentest in order to assist laboratories in the implementation and accreditation of NGS in a diagnostic setting. These guidelines mainly focused on Whole Exome Sequencing (WES) and targeted (gene panels) sequencing detecting small germline variants (Single Nucleotide Variants (SNVs) and insertions/deletions (indels)). Since then, Whole Genome Sequencing (WGS) has been increasingly introduced in the diagnosis of rare diseases as WGS allows the simultaneous detection of SNVs, Structural Variants (SVs) and other types of variants such as repeat expansions. The use of WGS in diagnostics warrants the re-evaluation and update of previously published guidelines. This work was jointly initiated by EuroGentest and the Horizon2020 project Solve-RD. Statements from the 2016 guidelines have been reviewed in the context of WGS and updated where necessary. The aim of these recommendations is primarily to list the points to consider for clinical (laboratory) geneticists, bioinformaticians, and (non-)geneticists, to provide technical advice, aid clinical decision-making and the reporting of the results.

14 March 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DHDanny Halim
Danny Halim
MWMichael P. Wilson
Michael P. Wilson
DODaniel Oliver
Daniel Oliver
Erwin BrosensErwin Brosens
Erwin Brosens
JVJoke B. G. M. Verheij
Joke B. G. M. Verheij
JMJoseph M. Miano
Joseph M. Miano
Significance: Rare recessive monogenic diseases are often found in isolated populations. In one such population, we identified a child carrying a homozygous nonsense mutation in an understudied smooth muscle-restricted gene called Leiomodin1 ( LMOD1 ). Heterozygous parents showed no disease; however, the child died shortly after birth from a rare condition known as megacystis microcolon intestinal hypoperistalsis syndrome. A mouse model with a similar Lmod1 mutation, engineered with CRISPR-Cas9 genome editing, exhibited the same gastrointestinal and urinary bladder phenotypes as seen in the newborn child. Phenotyping revealed insights into the underlying cause of the disease. Results demonstrate the conserved function of LMOD1 in human and mice and the importance of this protein in the molecular regulation of contractility in visceral smooth muscle cells.

1 June 2014 in Kidney International
Verified
Journal Article
Open access
PDF file
PSPawaree Saisawat
Pawaree Saisawat
SKStefan Kohl
Stefan Kohl
AHAlina C. Hilger
Alina C. Hilger
DHDaw-Yang Hwang
Daw-Yang Hwang
HGHeon Yung Gee
Heon Yung Gee
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
Congenital abnormalities of the kidney and urinary tract (CAKUT) account for approximately half of children with chronic kidney disease and they are the most frequent cause of end-stage renal disease in children in the US. However, its genetic etiology remains mostly elusive. VACTERL association is a rare disorder that involves congenital abnormalities in multiple organs including the kidney and urinary tract in up to 60% of the cases. By homozygosity mapping and whole-exome resequencing combined with high-throughput mutation analysis by array-based multiplex PCR and next-generation sequencing, we identified recessive mutations in the gene TNF receptor–associated protein 1 (TRAP1) in two families with isolated CAKUT and three families with VACTERL association. TRAP1 is a heat-shock protein 90–related mitochondrial chaperone possibly involved in antiapoptotic and endoplasmic reticulum stress signaling. Trap1 is expressed in renal epithelia of developing mouse kidney E13.5 and in the kidney of adult rats, most prominently in proximal tubules and in thick medullary ascending limbs of Henle’s loop. Thus, we identified mutations in TRAP1 as highly likely causing CAKUT or VACTERL association with CAKUT.

1 February 2016 in JACC
Verified
Journal Article
Closed access
RARowida Almomani
Rowida Almomani
JVJudith M.A. Verhagen
Judith M.A. Verhagen
JHJohanna C. Herkert
Johanna C. Herkert
Erwin BrosensErwin Brosens
Erwin Brosens
KSKarin Y. van Spaendonck-Zwarts
Karin Y. van Spaendonck-Zwarts
ILIngrid M.B.H. van de Laar
Ingrid M.B.H. van de Laar